﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2014v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2015-11-12T14:50:10-06:00</ReturnTs>
    <TaxPeriodEndDt>2014-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>521855942</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>TATE AND TRYON</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>2021 L STREET NW SUITE 400</AddressLine1Txt>
        <CityNm>WASHINGTON</CityNm>
        <StateAbbreviationCd>DC</StateAbbreviationCd>
        <ZIPCd>20036</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2014-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>231682043</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>AMERICAN SOCIETY FOR CLINICAL</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>PHARMACOLOGY AND THERAPEUTICS</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>AMER</BusinessNameControlTxt>
      <PhoneNum>7038366981</PhoneNum>
      <USAddress>
        <AddressLine1Txt>528 NORTH WASHINGTON STREET</AddressLine1Txt>
        <CityNm>ALEXANDRIA</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>22314</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>SHARON SWAN</PersonNm>
      <PersonTitleTxt>CHIEF EXECUTIVE OFFICER</PersonTitleTxt>
      <PhoneNum>7038366981</PhoneNum>
      <SignatureDt>2015-11-12</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>FREDERICK LONGWOOD</PreparerPersonNm>
      <PTIN>P00439715</PTIN>
      <PhoneNum>2022932200</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2014</TaxYr>
    <BuildTS>2016-02-25 16:41:14Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="8">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>SHARON SWAN</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>528 NORTH WASHINGTON STREET</AddressLine1Txt>
        <CityNm>ALEXANDRIA</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>22314</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>3634061</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ASCPT.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1900</FormationYr>
      <LegalDomicileStateCd>DC</LegalDomicileStateCd>
      <ActivityOrMissionDesc>ADVANCING THE SCIENCE AND PRACTICE OF CLINICAL PHARMACOLOGY FOR THE THERAPEUTIC BENEFIT OF PATIENTS AND SOCIETY.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>11</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>11</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>7</TotalEmployeeCnt>
      <TotalVolunteersCnt>400</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>3987</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>88684</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>46169</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>1663807</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>2387231</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>42235</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>83339</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>974103</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>797251</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>2768829</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>3313990</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>27500</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>39000</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>885338</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>984084</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>9350</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>3782</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>3782</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>1744365</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>1742432</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>2666553</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>2769298</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>102276</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>544692</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>5226153</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>5813029</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>251820</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>218211</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>4974333</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>5594818</NetAssetsOrFundBalancesEOYAmt>
      <MissionDesc>ADVANCING THE SCIENCE AND PRACTICE OF CLINICAL PHARMACOLOGY FOR THE THERAPEUTIC BENEFIT OF PATIENTS AND SOCIETY.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>1364956</ExpenseAmt>
      <GrantAmt>39000</GrantAmt>
      <RevenueAmt>1737110</RevenueAmt>
      <Desc>THE ASCPT ANNUAL MEETING IS AN INTERNATIONAL MEETING THAT ATTRACTS PARTICIPANTS FROM AROUND THE WORLD. A SPECTRUM OF TOPICS RELATING TO THE CONTINUUM OF DRUG DISCOVERY, DEVELOPMENT, REGULATION AND UTILIZATION ARE DISCUSSED. THE MEETING OFFERS EDUCATIONAL SESSIONS AND POSTER PRESENTATIONS, LECTURES FROM TOP PROFESSIONALS IN THE INDUSTRY, AS WELL AS NETWORKING OPPORTUNITIES WITH CLINICAL PHARMACOLOGISTS FROM AROUND THE WORLD. THERE IS ALSO AN EXHIBIT HALL WITH REPRESENTATIVES FROM VARIOUS COMPANIES.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>871485</ExpenseAmt>
        <Desc>CLINICAL PHARMACOLOGY AND THERAPEUTICS (CPT) IS THE AUTHORITATIVE CROSS-DISCIPLINARY JOURNAL IN EXPERIMENTAL AND CLINICAL MEDICINE DEVOTED TO PUBLISHING ADVANCES IN THE NATURE, ACTION, EFFICACY AND EVALUATION OF THERAPEUTICS. IT CONTINUES TO SEE IMPROVEMENTS IN THE NUMBER OF MANUSCRIPTS RECEIVED AND INCREASES IN SUBSCRIPTIONS.CPT: PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY (CPT:PSP) IS AN ONLINE, FULLY OPEN ACCESS JOURNAL. CPT:PSP PROVIDES A UNIQUE INTERNATIONAL FORUM FOR SCIENTISTS IN THE PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY SPACE.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>400017</ExpenseAmt>
        <RevenueAmt>650121</RevenueAmt>
        <Desc>MEMBERSHIP IN ASCPT OFFERS A NUMBER OF BENEFITS WHICH DIRECTLY IMPACT ITS MEMBERS AND THEIR PROFESSIONAL DEVELOPMENT. IT PROVIDES A VARIETY OF INFORMATION TOOLS, SUCH AS THE CPT JOURNAL, WEBSITE AND EMAIL NEWSLETTER, EDUCATIONAL OPPORTUNITIES, SUCH AS THE ANNUAL MEETING, AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>2636458</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd referenceDocumentId="RetDoc1039600001">0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="RetDoc1039600001">1</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd referenceDocumentId="RetDoc1039600001">0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">1</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">1</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">0</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">1</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>0</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>37</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>7</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>0</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>1</UnrelatedBusIncmOverLimitInd>
      <Form990TFiledInd>1</Form990TFiledInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>11</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>11</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>1</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>1</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>1</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>THE SOCIETY</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>7038366981</PhoneNum>
        <USAddress>
          <AddressLine1Txt>528 NORTH WASHINGTON STREET</AddressLine1Txt>
          <CityNm>ALEXANDRIA</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>22314</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN A WAGNER PHD</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RUSS ALTMAN MD PHD</PersonNm>
        <TitleTxt>IMMEDIATE PAST PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GREGORY L KEARNS PHARMDPHD</PersonNm>
        <TitleTxt>SECRETARY TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SASKIA DE WILDT MD PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MAURICE EMERY PHARMD PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>WALTER KRAFT MD FACP</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KELLIE SCHOOLAR REYNOLDS PHARMD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANNE ZAJICEK MD PHARMD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARIO ROCCI JR PHD</PersonNm>
        <TitleTxt>PRESIDENT-ELECT</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KIM L ROWSE BROUWER PHARMD PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SHARON J SWAN</PersonNm>
        <TitleTxt>CHIEF EXECUTIVE OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>361296</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>32108</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>361296</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>32108</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>FREEMAN AUDIO VISUAL SOLUTIONS INC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>PO BOX 650519</AddressLine1Txt>
            <CityNm>DALLAS</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>752650519</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>AUDIO VISUAL SERVICES</ServicesDesc>
        <CompensationAmt>234659</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>1</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>46169</AllOtherContributionsAmt>
      <TotalContributionsAmt>46169</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>REGISTRATION FEES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>973166</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>973166</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>MEMBERSHIP DUES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>650121</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>650121</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>SIGNING BONUS JOURNAL</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>500000</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>500000</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>EXHIBITS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>188500</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>188500</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>AM SPONSORSHIPS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>75444</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>75444</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>2387231</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>96095</TotalRevenueColumnAmt>
        <ExclusionAmt>96095</ExclusionAmt>
      </InvestmentIncomeGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>766010</TotalRevenueColumnAmt>
        <ExclusionAmt>766010</ExclusionAmt>
      </RoyaltiesRevenueGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>307315</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>320071</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>-12756</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>-12756</TotalRevenueColumnAmt>
        <ExclusionAmt>-12756</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>31241</TotalRevenueColumnAmt>
        <ExclusionAmt>31241</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>31241</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>3313990</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>2387231</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>880590</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>39000</TotalAmt>
        <ProgramServicesAmt>39000</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>393403</TotalAmt>
        <ProgramServicesAmt>303244</ProgramServicesAmt>
        <ManagementAndGeneralAmt>90159</ManagementAndGeneralAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>485851</TotalAmt>
        <ProgramServicesAmt>382727</ProgramServicesAmt>
        <ManagementAndGeneralAmt>103124</ManagementAndGeneralAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>27682</TotalAmt>
        <ProgramServicesAmt>21807</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5875</ManagementAndGeneralAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>26512</TotalAmt>
        <ProgramServicesAmt>1504</ProgramServicesAmt>
        <ManagementAndGeneralAmt>25008</ManagementAndGeneralAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>50636</TotalAmt>
        <ProgramServicesAmt>40622</ProgramServicesAmt>
        <ManagementAndGeneralAmt>10014</ManagementAndGeneralAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>21133</TotalAmt>
        <ManagementAndGeneralAmt>21133</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>80596</TotalAmt>
        <ManagementAndGeneralAmt>80596</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>3782</TotalAmt>
        <FundraisingAmt>3782</FundraisingAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>19783</TotalAmt>
        <ManagementAndGeneralAmt>19783</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>208990</TotalAmt>
        <ProgramServicesAmt>199247</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9743</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>86764</TotalAmt>
        <ProgramServicesAmt>37738</ProgramServicesAmt>
        <ManagementAndGeneralAmt>49026</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>4619</TotalAmt>
        <ManagementAndGeneralAmt>4619</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>48503</TotalAmt>
        <ManagementAndGeneralAmt>48503</ManagementAndGeneralAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>49671</TotalAmt>
        <ProgramServicesAmt>36208</ProgramServicesAmt>
        <ManagementAndGeneralAmt>13463</ManagementAndGeneralAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>690341</TotalAmt>
        <ProgramServicesAmt>659810</ProgramServicesAmt>
        <ManagementAndGeneralAmt>30531</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>55327</TotalAmt>
        <ManagementAndGeneralAmt>55327</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>22784</TotalAmt>
        <ManagementAndGeneralAmt>22784</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>AWARDS/HONORARIUM</Desc>
        <TotalAmt>162807</TotalAmt>
        <ProgramServicesAmt>161916</ProgramServicesAmt>
        <ManagementAndGeneralAmt>891</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>CPT SUBSCRIPTIONS</Desc>
        <TotalAmt>74377</TotalAmt>
        <ProgramServicesAmt>74377</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>STRATEGIC PLAN</Desc>
        <TotalAmt>61333</TotalAmt>
        <ProgramServicesAmt>3561</ProgramServicesAmt>
        <ManagementAndGeneralAmt>57772</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>EDITORIAL EXPENSES</Desc>
        <TotalAmt>50052</TotalAmt>
        <ProgramServicesAmt>50052</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>105352</TotalAmt>
        <ProgramServicesAmt>624645</ProgramServicesAmt>
        <ManagementAndGeneralAmt>-519293</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>2769298</TotalAmt>
        <ProgramServicesAmt>2636458</ProgramServicesAmt>
        <ManagementAndGeneralAmt>129058</ManagementAndGeneralAmt>
        <FundraisingAmt>3782</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>1519042</BOYAmt>
        <EOYAmt>1901631</EOYAmt>
      </CashNonInterestBearingGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>1905</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>1113079</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>349658</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>790188</BOYAmt>
        <EOYAmt>763421</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>2322652</BOYAmt>
        <EOYAmt>2573677</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <IntangibleAssetsGrp>
        <BOYAmt>594271</BOYAmt>
        <EOYAmt>572395</EOYAmt>
      </IntangibleAssetsGrp>
      <TotalAssetsGrp>
        <BOYAmt>5226153</BOYAmt>
        <EOYAmt>5813029</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>31083</BOYAmt>
        <EOYAmt>41342</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <MortgNotesPyblScrdInvstPropGrp>
        <BOYAmt>220737</BOYAmt>
        <EOYAmt>176869</EOYAmt>
      </MortgNotesPyblScrdInvstPropGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>251820</BOYAmt>
        <EOYAmt>218211</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>4717257</BOYAmt>
        <EOYAmt>5327034</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>257076</BOYAmt>
        <EOYAmt>267784</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>4974333</BOYAmt>
        <EOYAmt>5594818</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>5226153</BOYAmt>
        <EOYAmt>5813029</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>544692</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>75793</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingOtherInd methodOfAccountingOtherDesc="modified cash">X</MethodOfAccountingOtherInd>
      <AccountantCompileOrReviewInd>1</AccountantCompileOrReviewInd>
      <AcctCompileOrReviewBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </AcctCompileOrReviewBasisGrp>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>790550</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>780211</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>727314</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>652399</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>696289</CurrentTaxYearAmt>
        <TotalAmt>3646763</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>790550</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>780211</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>727314</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>652399</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>696289</CurrentTaxYearAmt>
        <TotalAmt>3646763</TotalAmt>
      </TotalCalendarYear170Grp>
      <PublicSupportTotal170Amt>3646763</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>995716</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>854059</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1074743</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1041798</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1056745</CurrentTaxYearAmt>
        <TotalAmt>5023061</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <CurrentTaxYearMinus4YearsAmt>13429</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>11067</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>14358</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>14302</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>53156</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>12250</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>6537</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>18301</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1885</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>31241</CurrentTaxYearAmt>
        <TotalAmt>70214</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>8793194</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>6351582</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.41470</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.43970</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleC documentId="RetDoc1039600001">
      <OtherExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>2740924</FilingOrganizationsTotalAmt>
      </OtherExemptPurposeExpendGrp>
      <TotalExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>2740924</FilingOrganizationsTotalAmt>
      </TotalExemptPurposeExpendGrp>
      <LobbyingNontaxableAmountGrp>
        <FilingOrganizationsTotalAmt>287046</FilingOrganizationsTotalAmt>
      </LobbyingNontaxableAmountGrp>
      <GrassrootsNontaxableGrp>
        <FilingOrganizationsTotalAmt>71762</FilingOrganizationsTotalAmt>
      </GrassrootsNontaxableGrp>
      <TotLbbyngGrassrootMnsNonTxGrp>
        <FilingOrganizationsTotalAmt>0</FilingOrganizationsTotalAmt>
      </TotLbbyngGrassrootMnsNonTxGrp>
      <TotLbbyExpendMnsLbbyngNonTxGrp>
        <FilingOrganizationsTotalAmt>0</FilingOrganizationsTotalAmt>
      </TotLbbyExpendMnsLbbyngNonTxGrp>
      <AvgLobbyingNontaxableAmountGrp>
        <CurrentYearMinus3Amt>279172</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>296968</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>281814</CurrentYearMinus1Amt>
        <CurrentYearAmt>287046</CurrentYearAmt>
        <TotalAmt>1145000</TotalAmt>
      </AvgLobbyingNontaxableAmountGrp>
      <LobbyingCeilingAmt>1717500</LobbyingCeilingAmt>
      <AvgGrassrootsNontaxableGrp>
        <CurrentYearMinus3Amt>69793</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>74242</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>70454</CurrentYearMinus1Amt>
        <CurrentYearAmt>71762</CurrentYearAmt>
        <TotalAmt>286251</TotalAmt>
      </AvgGrassrootsNontaxableGrp>
      <GrassrootsCeilingAmt>429377</GrassrootsCeilingAmt>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>471079</BeginningYearBalanceAmt>
        <ContributionsAmt>6043</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>26911</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>47961</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>4220</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>451852</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>411569</BeginningYearBalanceAmt>
        <ContributionsAmt>60083</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>45311</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>42119</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>3765</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>471079</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>427130</BeginningYearBalanceAmt>
        <ContributionsAmt>59572</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>29502</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>101627</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>3008</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>411569</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>400285</BeginningYearBalanceAmt>
        <ContributionsAmt>56125</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>6360</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>32767</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>2873</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>427130</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>283468</BeginningYearBalanceAmt>
        <ContributionsAmt>104917</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>27665</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>13518</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>2247</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>400285</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.54570</BoardDesignatedBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.45430</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>0</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>0</EndowmentsHeldRelatedOrgInd>
      <LandGrp>
        <OtherCostOrOtherBasisAmt>186000</OtherCostOrOtherBasisAmt>
        <BookValueAmt>186000</BookValueAmt>
      </LandGrp>
      <BuildingsGrp>
        <OtherCostOrOtherBasisAmt>577816</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>163715</DepreciationAmt>
        <BookValueAmt>414101</BookValueAmt>
      </BuildingsGrp>
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>195657</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>53809</DepreciationAmt>
        <BookValueAmt>141848</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>128486</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>107014</DepreciationAmt>
        <BookValueAmt>21472</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>25120</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>25120</DepreciationAmt>
        <BookValueAmt>0</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>763421</TotalBookValueLandBuildingsAmt>
      <OtherSecuritiesGrp>
        <Desc>CORPORATE BONDS</Desc>
        <BookValueAmt>907813</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <OtherSecuritiesGrp>
        <Desc>EQUITIES &amp; MUTUAL FUNDS</Desc>
        <BookValueAmt>1665864</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <TotalBookValueSecuritiesAmt>2573677</TotalBookValueSecuritiesAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>3389783</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>75793</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>75793</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>3313990</RevenueSubtotalAmt>
      <RevenueNotReportedFinclStmtAmt>0</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>3313990</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>2769298</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesNotReportedAmt>0</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>2769298</ExpensesSubtotalAmt>
      <ExpensesNotRptFinclStmtAmt>0</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>2769298</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART V, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>PURPOSE OF ENDOWMENT: THE BOARD OF DIRECTORS HAS DESIGNATED CASH AND INVESTMENTS TO BE SET ASIDE TO MEET AT LEAST THREE MONTHS WORTH OF OPERATING EXPENSES. THE BOARD HAS ALSO DESIGNATED CERTAIN INVESTMENTS AND THE INCOME RELATED TO THOSE INVESTMENTS ACCOUNTS FOR PAYMENT OF THE SOCIETY'S AWARD PROGRAMS AT ITS ANNUAL MEETING. THE AWARDS PROGRAM FOR WHICH INVESTMENTS HAVE BEEN SET ASIDE INCLUDE THE WILLIAM B. ABRAMS AWARD, THE RAWLS-PALMER AWARD, AND THE SCIENTIFIC AWARDS COMMITTEE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SOCIETY HAS EVALUATED ITS TAX POSITIONS FOR ALL OPEN TAX YEARS. CURRENTLY, THE TAX YEARS OPEN AND SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE ARE THE 2012, 2013, AND 2014 TAX YEARS. HOWEVER, THE SOCIETY IS NOT CURRENTLY UNDER AUDIT. BASED ON THE EVALUATION OF THE SOCIETY?S TAX POSITIONS, MANAGEMENT BELIEVES ALL TAX POSITIONS TAKEN WOULD BE UPHELD UNDER AN EXAMINATION. THEREFORE, NO PROVISIONS FOR THE EFFECTS OF UNCERTAIN TAX POSITIONS HAVE BEEN RECORDED FOR THE YEAR ENDED DECEMBER 31, 2014.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>FDA ABRAMS AWARD LECTURE</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>GARY NEIL PRIZE</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>2500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>HENRY W. ELLIOT DISTINGUISHED SERVICE AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>LEON I. GOLDBERG YOUNG INVESTIGATOR AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>OSCAR B. HUNTER MEMORIAL AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>ASCPT YOUNG INVESTIGATOR AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>17500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>HONORARIUM-2014 ANNUAL MEETING</GrantTypeTxt>
        <RecipientCnt>3</RecipientCnt>
        <CashGrantAmt>3000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>PRES TRAINEE AWARD</GrantTypeTxt>
        <RecipientCnt>24</RecipientCnt>
        <CashGrantAmt>12000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ASCPT MAINTAINS RECORDS TO SUBSTANTIATE THE AMOUNT OF GRANTS OR ASSISTANCE, THE GRANTEES' ELIGIBILITY FOR THE GRANTS, AND THE SELECTION CRITERIA USED TO AWARD THE GRANTS. EACH YEAR ASCPT'S AWARDS PROGRAM PROVIDES AN ARRAY OF AWARDS THAT RECOGNIZE OUTSTANDING SCIENCE AND ACHIEVEMENT IN CLINICAL PHARMACOLOGY. ASCPT'S AWARDS SPAN THE CONTINUUM OF CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE, AND THERAPEUTICS. THE ARRAY OF AWARDS IS DESIGNED TO RECOGNIZE EVERY TURNING POINT IN THE CAREER PATH FROM YOUNG INVESTIGATOR TO SEASONED SCIENTIST WITH THE FOCUS ON EXCEPTIONAL ACHIEVEMENTS IN THE DIMENSIONS THAT THE AWARDS ARE FOCUSED. CANDIDATES ARE NOMINATED BY COLLEAGUES FOR CONSIDERATION FOR AN ASCPT AWARD. ALL NOMINATIONS ARE VETTED BY AN APPOINTED AWARDS SELECTION TASK FORCE COMPRISED OF ASCPT MEMBERS. LETTERS OF RECOMMENDATION AND CURRICULUM VITAE ARE REVIEWED AND ULTIMATELY DECISIONS ARE MADE BY THE AWARDS SELECTION TASK FORCE ON EACH RECIPIENT OF AN ASCPT AWARD. GARY NEIL PRIZE FOR INNOVATION IN DRUG DEVELOPMENT ELIGIBILITY: INDIVIDUALS AS WELL AS TEAMS WHO HAVE DEMONSTRATED LEADERSHIP IN THE APPLICATION OF SIGNIFICANT, INNOVATIVE SCIENCE TO CLINICAL DRUG DEVELOPMENT. THE AWARD IS OPEN TO INDIVIDUALS FROM ALL CLINICAL PHARMACOLOGY EMPLOYMENT SECTORS. PRIZE AND PRESENTATION: THE GARY NEIL PRIZE FOR INNOVATION IN DRUG DEVELOPMENT WILL BE PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL RECEIVE A PLAQUE AND A $2,500 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. LEON I. GOLDBERG EARLY INVESTIGATOR AWARD* *PREVIOUSLY LEON I. GOLDBERG YOUNG INVESTIGATOR AWARD FROM 1986-2015 ELIGIBILITY: THE NOMINEE CAN BE AN ACADEMIC, INDUSTRIAL, OR REGULATORY SCIENTIST WHO HAS MADE A SUBSTANTIAL CONTRIBUTION TO CLINICAL PHARMACOLOGY WITHIN 10 YEARS OF THE COMPLETION OF AN ADVANCED DEGREE AND/OR A POST-DOCTORAL FELLOWSHIP OR RESIDENCY PROGRAM. AN IMPORTANT ASPECT IS THAT THE RECIPIENT WILL BE ABLE TO DELIVER AN ENGAGING PRESENTATION ABOUT THE IMPACT OF HIS/HER RESEARCH. THE AWARD IS INTENDED TO FOSTER THE CANDIDATE'S POTENTIAL FOR SIGNIFICANT CONTRIBUTIONS TO THE FUTURE OF CLINICAL PHARMACOLOGY. THE NOMINATOR'S ASSESSMENT AND LETTERS OF RECOMMENDATION SHOULD CONTAIN EVIDENCE THAT THE CANDIDATE HAS DOCUMENTED SCIENTIFIC CONTRIBUTIONS, AS EVIDENCED BY EITHER WELL CITED PUBLICATIONS, GRANTS, PATENTS, INDEPENDENT INFLUENCE ON IMPORTANT DRUG DEVELOPMENT OR REGULATORY DECISIONS, OR OTHER RECOGNITIONS AS MAY BE RELEVANT. THERE ARE NO RESTRICTIONS CONCERNING THE SCIENTIFIC FIELD IN WHICH NOMINEES HAVE EARNED THEIR DOCTORAL DEGREES. ALTHOUGH IT IS ENCOURAGED, A NOMINEE NEED NOT BE A MEMBER OF THE SOCIETY. PRIZE AND PRESENTATION: THE LEON I. GOLDBERG EARLY INVESTIGATOR AWARD IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL DELIVER A LECTURE ON HIS/HER WORK. IN ADDITION, THE RECIPIENT OF THE AWARD WILL RECEIVE A PLAQUE AND A $1,000 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION ARE REIMBURSED BY THE SOCIETY OSCAR B. HUNTER CAREER AWARD IN THERAPEUTICS* *PREVIOUSLY OSCAR B. HUNTER MEMORIAL AWARD FROM 1955-2015 ELIGIBILITY: THE NOMINEE CAN BE AN ACADEMIC, INDUSTRIAL, OR REGULATORY SCIENTIST WHO HAS DEMONSTRATED A SUSTAINED RECORD OF LIFELONG CONTRIBUTIONS TO CLINICAL PHARMACOLOGY AND DISSEMINATION OF KNOWLEDGE WHO WILL BE ABLE TO GIVE AN ENGAGING PRESENTATION ABOUT HIS/HER CAREER AND THE IMPACT OF HIS/HER WORK. THE NOMINATOR'S ASSESSMENT AND LETTERS OF RECOMMENDATION SHOULD PROVIDE EVIDENCE OF THE NOMINEE'S EXEMPLARY CAREER AS A LEADER, INCLUDING SUFFICIENT DOCUMENTED SCIENTIFIC CONTRIBUTIONS, AS EVIDENCED BY EITHER HIGH IMPACT PUBLICATIONS, PATENTS, INDEPENDENT INFLUENCE ON IMPORTANT DRUG DISCOVERY, DRUG DEVELOPMENT OR REGULATORY DECISIONS, OR OTHER RECOGNITIONS AS MAY BE RELEVANT. PARTICULAR EMPHASIS SHOULD BE PROVIDED ON THE LIFETIME CONTRIBUTIONS OF THIS NOMINEE AND THE IMPACT OF HIS/HER ACCOMPLISHMENT TO CLINICAL PHARMACOLOGY. THE NOMINEE MUST BE A WELL-RECOGNIZED LEADER IN CLINICAL PHARMACOLOGY, BUT DOES NOT NEED TO BE AN ASCPT MEMBER. PRIZE AND PRESENTATION: THE OSCAR B. HUNTER CAREER AWARD IN THERAPEUTICS IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL PRESENT A LECTURE SUMMARIZING THE WORKS THAT FORM THE BASIS OF THE AWARD. IN ADDITION, THE RECIPIENT OF THE AWARD WILL RECEIVE A BRONZE MEDAL MOUNTED ON A PLAQUE AND A $1,500 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. RAWLS-PALMER PROGRESS IN MEDICINE AWARD ELIGIBILITY: A NOMINEE CAN BE AN ACADEMIC, INDUSTRIAL, OR REGULATORY SCIENTIST WHO IS WIDELY RECOGNIZED FOR HIS/HER TRANSFORMATIONAL AND/OR TRANSLATIONAL DISCOVERIES OR INNOVATIVE APPROACHES IMPACTING CLINICAL PHARMACOLOGY RESEARCH AND CLINICAL PRACTICE. THE NOMINATOR'S ASSESSMENT AND LETTER(S) OF RECOMMENDATION SHOULD PROVIDE EVIDENCE OF THE NOMINEE'S EXEMPLARY RECORD, INCLUDING SUFFICIENT DOCUMENTED SCIENTIFIC CONTRIBUTIONS FROM RESEARCH THAT LEAD TO DIRECT APPLICATIONS IN PATIENT CARE, AS EVIDENCED BY EITHER WELL CITED PUBLICATIONS, PATENTS, INDEPENDENT INFLUENCE ON IMPORTANT DRUG DEVELOPMENT OR REGULATORY DECISIONS, OR OTHER RECOGNITIONS (AS MAY BE RELEVANT). A NOMINEE DOES NOT NEED TO BE AN ASCPT MEMBER. PRIZE AND PRESENTATION: THE RAWLS-PALMER PROGRESS IN MEDICINE AWARD IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL PRESENT A LECTURE FOCUSING ON RECENT DEVELOPMENTS IN CLINICAL PHARMACOLOGY. IN ADDITION, THE RECIPIENT WILL RECEIVE A $1,000 PRIZE AND A PLAQUE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. SHEINER-BEAL PHARMACOMETRICS AWARD ELIGIBILITY: THE CANDIDATE MUST BE AN INVESTIGATOR OR LEADER WHO IS ACTIVELY ADVANCING THE SCIENTIFIC DISCIPLINE OF PHARMACOMETRICS AND/OR ITS IMPACT ON RESEARCH, DEVELOPMENT, REGULATORY EVALUATION, OR UTILIZATION OF THERAPEUTIC PRODUCTS, AND IS CAPABLE OF DELIVERING AN ENGAGING AND COMPREHENSIVE LECTURE ON PHARMACOMETRICS. THE AWARD IS INTENDED TO RECOGNIZE CLINICAL PHARMACOLOGISTS, CLINICIAN SCIENTISTS, COMPUTATIONAL SCIENTISTS, STATISTICIANS AND OTHERS IN ACADEMIA, INDUSTRY, GOVERNMENT AGENCIES, OR CONSULTING WHOSE WORK FALLS WITHIN THE SCOPE OF THE DEFINITION OF PHARMACOMETRICS. PRIZE AND PRESENTATION: THE SHEINER-BEAL PHARMACOMETRICS AWARD WILL BE PRESENTED ANNUALLY AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL PRESENT A LECTURE SUMMARIZING THE WORKS THAT FORM THE BASIS OF THE AWARD. IN ADDITION, THE RECIPIENT WILL RECEIVE A $1,500 PRIZE AND A PLAQUE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. WILLIAM B. ABRAMS AWARD IN GERIATRIC CLINICAL PHARMACOLOGY ELIGIBILITY: A NOMINEE MUST BE AN INVESTIGATOR IN GERIATRICS WHO IS ACTIVELY INVOLVED IN HIGH-QUALITY TEACHING AND RESEARCH IN GERIATRIC CLINICAL PHARMACOLOGY. PRIZE AND PRESENTATION: THE WILLIAM B. ABRAMS AWARD IN GERIATRIC CLINICAL PHARMACOLOGY IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL RECEIVE A PLAQUE AND A $1,000 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. HENRY W. ELLIOTT DISTINGUISHED SERVICE AWARD ELIGIBILITY: A NOMINEE MUST BE A MEMBER OF ASCPT AND CANNOT HAVE HELD THE POSITION OF PRESIDENT-ELECT OR PRESIDENT OF THE SOCIETY WITHIN THE LAST FIVE YEARS. THE ESSENTIAL CRITERION IS DOCUMENTED EVIDENCE OF EXCELLENT SERVICE TO THE ORGANIZATION. ONE OR TWO OUTSTANDING ACTS OF SERVICE OR A LONG RECORD OF MANY ACTS OF SERVICE MAY JUSTIFY THE AWARD. THE RECIPIENT SHOULD HAVE A RECORD OF CONTINUOUS SERVICE TO THE SOCIETY, INCLUDING ONE OR MANY MAJOR ACCOMPLISHMENTS. PRIZE AND PRESENTATION: THE HENRY W. ELLIOTT DISTINGUISHED SERVICE AWARD IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL RECEIVE A PLAQUE AND A $1,000 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>SHARON J SWAN</PersonNm>
        <TitleTxt>CHIEF EXECUTIVE OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>361296</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>23000</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>9108</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>393404</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SOCIETY HAS TWO CLASSES OF MEMBERS: FULL MEMBER AND TRAINEE/STUDENT MEMBER FULL MEMBER: FOR APPLICANTS WHO HAVE EARNED A DOCTORATE DEGREE OR EQUIVALENT IN ANY OF THE BIOMEDICAL SCIENCES. ALSO FOR APPLICANTS IN EXECUTIVE AND LEADERSHIP ROLES IN RELATED ORGANIZATIONS. APPLICANTS MUST DEMONSTRATE A SINCERE INTEREST IN, AND CONTRIBUTIONS TO, HUMAN PHARMACOLOGY AND THERAPEUTICS THROUGH PUBLICATIONS, GRANTS, PATENTS, GOVERNMENTAL REPORTS, COMPANY REPORTS, ETC. TRAINEE/STUDENT MEMBER: FOR APPLICANTS CURRENTLY ENROLLED IN A POST-DOCTORAL TRAINING PROGRAM WHO HAVE DEMONSTRATED AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS. ALSO FOR APPLICANTS WHO ARE PURSUING A POST-BACCALAUREATE DEGREE AND WHO POSSESS AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 7A</FormAndLineReferenceDesc>
        <ExplanationTxt>MEMBERS SHALL HAVE SUCH VOTING PRIVILEGES AS ARE DETERMINED FROM TIME TO TIME BY THE SOCIETY'S GOVERNING BOARD AND SHALL VOTE IN SUCH MANNER AS DETERMINED BY THE GOVERNING BOARD.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 7B</FormAndLineReferenceDesc>
        <ExplanationTxt>ANY CHANGES TO THE ORGANIZATION'S BYLAWS ARE SUBJECT TO APPROVAL BY THE FULL MEMBERS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FORM 990 IS REVIEWED BY THE ASCPT EXECUTIVE DIRECTOR AND ASCPT LEGAL COUNSEL FOLLOWING PREPARATION BY THE SOCIETY'S ACCOUNTANTS. THE OFFICERS OF ASCPT REVIEW THE DOCUMENT PRIOR TO IT BEING FILED. THE BOARD IS INFORMED ABOUT THE PREPARATION AND FILING OF THE FORM 990 AND THE RETURN IS MADE AVAILABLE AT ANY TIME TO ANY BOARD MEMBER FOR THEIR REVIEW.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THROUGH WRITTEN DISCLOSURES TO LEGAL COUNSEL.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>THE EXECUTIVE DIRECTOR'S COMPENSATION IS DETERMINED BY THE ASCPT COMPENSATION COMMITTEE USING COMPARABILITY DATA. COMPENSATION OF KEY EMPLOYEES IS DETERMINED BY THE EXECUTIVE DIRECTOR USING COMPARABILITY DATA.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON THE ASCPT WEB SITE. FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART IX, LINE 24E</FormAndLineReferenceDesc>
        <ExplanationTxt>BANK &amp; CREDIT CARD FEES: PROGRAM SERVICE EXPENSES 43,480. MANAGEMENT AND GENERAL EXPENSES 5,968. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 49,448. MISCELLANEOUS: PROGRAM SERVICE EXPENSES 28,080. MANAGEMENT AND GENERAL EXPENSES 11,256. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 39,336. TRAINING: PROGRAM SERVICE EXPENSES 3,874. MANAGEMENT AND GENERAL EXPENSES 12,411. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 16,285. TEMPORARY HELP: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 283. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 283.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 1:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SOCIETY PREPARES ITS FINANCIAL STATEMENTS ON THE MODIFIED CASH BASIS OF ACCOUTING. REVENUES ARE RECOGNIZED WHEN COLLECTED RATHER THAN WHEN EARNED, AND EXPENSES ARE GENERALLY RECOGNIZED WHEN PAID RATHER THAN WHEN INCURRED. THE MODIFIED CASH BASIS OF ACCOUNTING INCLUDES THE RECORDING OF DEPRECIATION ON PROPERTY AND EQIUPMENT, AND REALIZED AND UNREALIZED GAINS AND LOSSES ON INVESTMENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE AUDIT OVERSIGHT PROCESS REMAINS UNCHANGED FROM THE PRIOR YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>